Profil
Izhak Haviv is the founder and current Chief Scientific Officer of AID Genomics Group Ltd., which is founded in 2018.
Aktive Positionen von Izhak Haviv
| Unternehmen | Position | Beginn |
|---|---|---|
AID Genomics Group Ltd.
 AID Genomics Group Ltd. Pharmaceuticals: MajorHealth Technology AID Genomics Group Ltd. is a research and development driven Israeli company that focuses on precision medicine-based diagnostics for oncology, hereditary rare diseases, and infectious diseases. AID Genomics Group is based in Rehovot, IL and was founded in 2018 by King Shiu Wu, Snir Zano, and Izhak Haviv. The company's advanced testing platforms were developed by a team of experts in oncology, molecular biology, molecular pathology, genomics, and bioinformatics. Snir Zano has been the CEO since 2018. | Gründer | 01.01.2018 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
AID Genomics Group Ltd.
AID Genomics Group Ltd. Pharmaceuticals: MajorHealth Technology AID Genomics Group Ltd. is a research and development driven Israeli company that focuses on precision medicine-based diagnostics for oncology, hereditary rare diseases, and infectious diseases. AID Genomics Group is based in Rehovot, IL and was founded in 2018 by King Shiu Wu, Snir Zano, and Izhak Haviv. The company's advanced testing platforms were developed by a team of experts in oncology, molecular biology, molecular pathology, genomics, and bioinformatics. Snir Zano has been the CEO since 2018. | Health Technology |
